Withdrawal of Registration Statement (rw)
November 14 2014 - 06:02AM
Edgar (US Regulatory)
Calmare Therapeutics Incorporated
1375 Kings Highway East
Fairfield, CT 06824 33321
November
13, 2014
VIA EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
| Re: | Calmare Therapeutics Incorporated |
Registration
Statement on Form S-1
Filed
July 22, 2013
File
No. 333- 190069
Ladies and Gentlemen:
Pursuant to Rule 477 under the Securities
Act of 1933 (the “Act”), Calmare Therapeutics Incorporated (the “Company”) requests the withdrawal of the
Company’s Registration Statement on Form S-1 originally filed on July 22, 2013, File No. 333-190069 (the “S-1 Registration
Statement”). The Company has elected to withdraw the S-1 Registration Statement because it does not want to pursue an offering
at this time. No sales of the Company’s common stock have been or will be made pursuant to the S-1 Registration Statement.
The Company requests that in accordance
with Rule 457(p) under the Act, all fees paid to the Commission in connection with the filing of the above-captioned registration
statement be credited for future use. If you have any questions regarding this request for withdrawal, please contact our legal
counsel, Gregg E. Jaclin at (609) 275-0400.
Sincerely,
Calmare Therapeutics Incorporated
By: |
/s/
Conrad Mir |
|
Name: |
Conrad Mir |
|
Title: |
Chief Executive Officer |
|
Calmare Therapeutics (CE) (USOTC:CTTC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Calmare Therapeutics (CE) (USOTC:CTTC)
Historical Stock Chart
From Mar 2023 to Mar 2024